Literature DB >> 10390592

Inflammatory cecal masses in patients presenting with appendicitis.

R T Poon1, K W Chu.   

Abstract

An unexpected inflammatory cecal mass of uncertain etiology encountered during surgery for presumed appendicitis poses a dilemma to the surgeon when deciding the appropriate operative management. A retrospective study was performed to review the pathology and surgical management of this condition. Among 3224 patients who had emergency surgery for a diagnosis of acute appendicitis between January 1990 and December 1997, a group of 52 patients (1.6%) underwent either ileocecal resection or right hemicolectomy for an inflammatory cecal mass of uncertain etiology. The final pathologic diagnosis was cecal diverticulitis in 26 patients (50%), appendiceal phlegmon or abscess in 21 patients (40%), cecal carcinoma in 3 patients (6%), tuberculosis in 1 patient (2%) and schistosomiasis in another patient (2%). Altogether 34 patients underwent ileocecal resection, and 18 patients underwent right hemicolectomy, including the 3 patients with cecal carcinoma. Ileocecal resection was associated with a shorter mean operative time (144 vs. 201 minutes; p < 0.001), a lower morbidity rate (3% vs. 22%; p = 0.043), and a shortened mean postoperative hospital stay (6.8 vs. 11.2 days; p = 0. 011) than right hemicolectomy. There was no mortality in either group. In conclusion, most inflammatory cecal masses are due to benign pathologies and could be managed safely and sufficiently with ileocecal resection. Careful intraoperative assessment including examination of the resected specimen is essential to exclude malignancy, which would require right hemicolectomy.

Entities:  

Mesh:

Year:  1999        PMID: 10390592     DOI: 10.1007/pl00012374

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  15 in total

1.  Cecum cancer underlying appendicular abscess. Case report and review of literature.

Authors:  Irene Fiume; Vincenzo Napolitano; Gianmattia Del Genio; Alfredo Allaria; Alberto Del Genio
Journal:  World J Emerg Surg       Date:  2006-04-04       Impact factor: 5.469

Review 2.  Management of appendiceal mass: controversial issues revisited.

Authors:  Abdul-Wahed N Meshikhes
Journal:  J Gastrointest Surg       Date:  2007-11-13       Impact factor: 3.452

3.  Primary Appendicular Malignancy Presenting as Abdominal Wall Abscess with Secondary Tuberculosis Infection: an Interesting Case Report.

Authors:  Ritim Ravi Patel; Vipul Versi Nandu
Journal:  Indian J Surg Oncol       Date:  2018-08-07

4.  A case of pediatric cecal diverticulitis mimicking acute appendicitis.

Authors:  Justin T Huntington; William Brigode; Rajan K Thakkar; Mehul V Raval; Steven Teich
Journal:  Int J Colorectal Dis       Date:  2015-03-03       Impact factor: 2.571

5.  Management of right colon diverticulitis: a 10-year experience.

Authors:  Horng-Ren Yang; Huai-Hsu Huang; Yu-Chun Wang; Chi-Hsun Hsieh; Ping-Kuei Chung; Long-Bin Jeng; Ray-Jade Chen
Journal:  World J Surg       Date:  2006-10       Impact factor: 3.352

Review 6.  Management of appendiceal masses in a peripheral hospital in Nigeria: review of thirty cases.

Authors:  Pius I S Okafor; Jideofor C Orakwe; Gabriel U Chianakwana
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

7.  Management of Appendiceal Mass and Abscess. An 11-Year Experience.

Authors:  Zaza Demetrashvili; Giorgi Kenchadze; Irakli Pipia; Eka Ekaladze; George Kamkamidze
Journal:  Int Surg       Date:  2015-06

8.  Surgical pathology of schistosomiasis.

Authors:  Aminu Z Mohammed; Steven T Edino; Adamu A Samaila
Journal:  J Natl Med Assoc       Date:  2007-05       Impact factor: 1.798

9.  Schistosomiasis of the appendix.

Authors:  Callisto Madavo; Hisham Hurriez
Journal:  J R Soc Med       Date:  2006-09       Impact factor: 18.000

10.  Caecal diverticulitis presenting as acute appendicitis: a case report.

Authors:  Michelle Cole; Abraham A Ayantunde; John Payne
Journal:  World J Emerg Surg       Date:  2009-07-31       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.